Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
Human immunodeficiency virus and hepatitis B virus co-infection in two siblings: viral loads markedly reduced by triple-therapy including lamivudine.
Multicenter prospective study to optimize the efficacy of triple therapy with telaprevir in patients with genotype 1b hepatitis C virus infection according to an algorithm based on the drug Adherence, IL-28B Gene Allele and Viral Response Trial (AG & RGT).
Getting to HBV cure: The promising paths forward.
Fung S, Choi HSJ, Gehring A, Janssen HLA.
Hepatology. 2022 Jul;76(1):233-250. doi: 10.1002/hep.32314. Epub 2022 Feb 16.
Triple Threat: HDV, HBV, HIV Coinfection.
Yen DW, Soriano V, Barreiro P, Sherman KE.
Clin Liver Dis. 2023 Nov;27(4):955-972. doi: 10.1016/j.cld.2023.05.010. Epub 2023 Jul 1.
An overview of triple infection with hepatitis B, C and D viruses.
Riaz M, Idrees M, Kanwal H, Kabir F.
Virol J. 2011 Jul 27;8:368. doi: 10.1186/1743-422X-8-368.
Virological tools to diagnose and monitor hepatitis C virus infection.
Chevaliez S.
Clin Microbiol Infect. 2011 Feb;17(2):116-21. doi: 10.1111/j.1469-0691.2010.03418.x. Epub 2010 Dec 14.
Host genetics.
Macías J, Vispo E, Pineda JA, Soriano V.
Curr Opin HIV AIDS. 2011 Nov;6(6):491-500. doi: 10.1097/COH.0b013e32834bca2d.
Viral hepatitis B and C co-infection with Human Immunodeficiency Virus among adult patients attending selected highly active anti-retroviral therapy clinics in Nigeria's capital.
Anyanwu NCJ, Sunmonu PT, Mathew MH.
J Immunoassay Immunochem. 2020;41(2):171-183. doi: 10.1080/15321819.2019.1705852. Epub 2019 Dec 27.
Viral hepatitis C gets personal--the value of human genomics to public health.
Zhang L, Gwinn M, Hu DJ.
Public Health Genomics. 2013;16(4):192-7. doi: 10.1159/000352014. Epub 2013 Jul 11.
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial.
Yuen MF, Asselah T, Jacobson IM, Brunetto MR, Janssen HLA, Takehara T, Hou JL, Kakuda TN, Lambrecht T, Beumont M, Kalmeijer R, Guinard-Azadian C, Mayer C, Jezorwski J, Verbinnen T, Lenz O, Shukla U, Biermer M; REEF-1 Study Group.
Lancet Gastroenterol Hepatol. 2023 Sep;8(9):790-802. doi: 10.1016/S2468-1253(23)00148-6. Epub 2023 Jul 10.
Role of hepatitis C virus in dual and triple hepatitis virus infection.
Liaw YF.
Hepatology. 1995 Oct;22(4 Pt 1):1101-8. doi: 10.1016/0270-9139(95)90615-0.
Global Disparities in Hepatitis B Elimination-A Focus on Africa.
Sonderup MW, Spearman CW.
Viruses. 2022 Jan 3;14(1):82. doi: 10.3390/v14010082.
